Published in Pulm Pharmacol Ther on April 22, 2009
Cigarette smoke-induced mitochondrial fragmentation and dysfunction in human airway smooth muscle. Am J Physiol Lung Cell Mol Physiol (2014) 1.72
Vitamin D supplementation reduces airway hyperresponsiveness and allergic airway inflammation in a murine model. Clin Exp Allergy (2013) 1.70
Glucocorticoid receptor interacting protein-1 restores glucocorticoid responsiveness in steroid-resistant airway structural cells. Am J Respir Cell Mol Biol (2009) 0.97
Pro-inflammatory mechanisms of muscarinic receptor stimulation in airway smooth muscle. Respir Res (2010) 0.87
Does airway smooth muscle express an inflammatory phenotype in asthma? Br J Pharmacol (2011) 0.86
Large-scale profiling of signalling pathways reveals an asthma specific signature in bronchial smooth muscle cells. Oncotarget (2016) 0.83
Isoprostanes and asthma. Biochim Biophys Acta (2011) 0.80
Targeting airway smooth muscle in airways diseases: an old concept with new twists. Expert Rev Respir Med (2011) 0.79
Tidal stretches differently regulate the contractile and cytoskeletal elements in intact airways. PLoS One (2014) 0.77
Shared principles in NF-kappaB signaling. Cell (2008) 20.96
STATs and gene regulation. Science (1997) 16.55
IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science (1997) 11.89
Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol (1994) 8.98
Regulation and function of IKK and IKK-related kinases. Sci STKE (2006) 8.98
Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature (1986) 7.81
Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science (2001) 7.66
Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. Science (1999) 6.20
The JNK signal transduction pathway. Curr Opin Cell Biol (2007) 5.86
The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis. J Exp Med (1999) 5.79
Activation and signaling of the p38 MAP kinase pathway. Cell Res (2005) 5.48
The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways. Immunity (2002) 5.38
Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol (1999) 5.36
Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB. EMBO J (2002) 4.91
Series introduction: the transcription factor NF-kappaB and human disease. J Clin Invest (2001) 4.18
The MEK/ERK cascade: from signaling specificity to diverse functions. Biochim Biophys Acta (2006) 4.06
Limb and skin abnormalities in mice lacking IKKalpha. Science (1999) 3.85
A critical role for NF-kappa B in GATA3 expression and TH2 differentiation in allergic airway inflammation. Nat Immunol (2001) 3.74
Transcriptional activation by NF-kappaB requires multiple coactivators. Mol Cell Biol (1999) 3.11
Interferon regulatory factors: the next generation. Gene (1999) 2.98
The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness. J Exp Med (1998) 2.94
Cigarette smoke-induced pulmonary inflammation is TLR4/MyD88 and IL-1R1/MyD88 signaling dependent. J Immunol (2008) 2.83
STAT proteins and transcriptional responses to extracellular signals. Trends Biochem Sci (2000) 2.60
Essential role of nuclear factor kappaB in the induction of eosinophilia in allergic airway inflammation. J Exp Med (1998) 2.40
Activation of NF-kappa B in vivo is regulated by multiple phosphorylations. EMBO J (1994) 2.31
The IkappaB function of NF-kappaB2 p100 controls stimulated osteoclastogenesis. J Exp Med (2003) 2.20
Activation and localization of transcription factor, nuclear factor-kappaB, in asthma. Am J Respir Crit Care Med (1998) 2.19
Increased matrix metalloproteinase-9 in the airway after allergen challenge. Am J Respir Crit Care Med (2000) 2.18
The human glucocorticoid receptor beta isoform. Expression, biochemical properties, and putative function. J Biol Chem (1996) 2.13
Synergy between interferon-gamma and tumor necrosis factor-alpha in transcriptional activation is mediated by cooperation between signal transducer and activator of transcription 1 and nuclear factor kappaB. J Biol Chem (1997) 2.05
Activities of IRF-1. J Interferon Cytokine Res (2002) 2.04
Allergen-induced peribronchial fibrosis and mucus production mediated by IkappaB kinase beta-dependent genes in airway epithelium. Proc Natl Acad Sci U S A (2005) 1.87
Update on glucocorticoid action and resistance. J Allergy Clin Immunol (2003) 1.82
Targeting the NF-kappaB pathway in asthma and chronic obstructive pulmonary disease. Pharmacol Ther (2008) 1.74
NF-kappa B activation in airways modulates allergic inflammation but not hyperresponsiveness. J Immunol (2004) 1.73
Stress-induced phosphorylation of STAT1 at Ser727 requires p38 mitogen-activated protein kinase whereas IFN-gamma uses a different signaling pathway. Proc Natl Acad Sci U S A (1999) 1.72
Association of rhinovirus infections with asthma. Clin Microbiol Rev (1999) 1.70
Regulation of Toll-like receptor 4-induced proasthmatic changes in airway smooth muscle function by opposing actions of ERK1/2 and p38 MAPK signaling. Am J Physiol Lung Cell Mol Physiol (2006) 1.67
Rapid activation of nuclear factor-kappaB in airway epithelium in a murine model of allergic airway inflammation. Am J Pathol (2002) 1.66
Lipoteichoic acid-stimulated p42/p44 MAPK activation via Toll-like receptor 2 in tracheal smooth muscle cells. Am J Physiol Lung Cell Mol Physiol (2004) 1.64
Constitutive activation of an epithelial signal transducer and activator of transcription (STAT) pathway in asthma. J Clin Invest (1999) 1.60
Latent adenoviral infection modifies the steroid response in allergic lung inflammation. J Allergy Clin Immunol (2000) 1.60
T lymphocytes adhere to airway smooth muscle cells via integrins and CD44 and induce smooth muscle cell DNA synthesis. J Exp Med (1994) 1.55
NF-kappa B/Rel transcription factors: c-Rel promotes airway hyperresponsiveness and allergic pulmonary inflammation. J Immunol (1999) 1.51
TLR2 agonist ameliorates established allergic airway inflammation by promoting Th1 response and not via regulatory T cells. J Immunol (2005) 1.41
'Tuning' of type I interferon-induced Jak-STAT1 signaling by calcium-dependent kinases in macrophages. Nat Immunol (2007) 1.40
Human airway smooth muscle cells express and release RANTES in response to T helper 1 cytokines: regulation by T helper 2 cytokines and corticosteroids. J Immunol (1997) 1.38
Induction of Jak/STAT signaling by activation of the type 1 TNF receptor. J Immunol (1998) 1.37
Nuclear translocation of p65 NF-kappaB is sufficient for VCAM-1, but not ICAM-1, expression in TNF-stimulated smooth muscle cells: Differential requirement for PARP-1 expression and interaction. Cell Signal (2007) 1.35
Interleukin-1beta induces MMP-9 expression via p42/p44 MAPK, p38 MAPK, JNK, and nuclear factor-kappaB signaling pathways in human tracheal smooth muscle cells. J Cell Physiol (2007) 1.34
IL-13 and IL-4 cause eotaxin release in human airway smooth muscle cells: a role for ERK. Am J Physiol Lung Cell Mol Physiol (2002) 1.34
Stat1 as a component of tumor necrosis factor alpha receptor 1-TRADD signaling complex to inhibit NF-kappaB activation. Mol Cell Biol (2000) 1.33
Toll-like receptor 4 or 2 agonists decrease allergic inflammation. Am J Respir Cell Mol Biol (2004) 1.31
Allergic airway inflammation inhibits pulmonary antibacterial host defense. J Immunol (2006) 1.31
Toll-like receptor 2, 3, and 4 expression and function in human airway smooth muscle. J Allergy Clin Immunol (2006) 1.31
Cooperative molecular and cellular networks regulate Toll-like receptor-dependent inflammatory responses. FASEB J (2006) 1.30
MAPK superfamily activation in human airway smooth muscle: mitogenesis requires prolonged p42/p44 activation. Am J Physiol (1999) 1.29
IL-17A induces eotaxin-1/CC chemokine ligand 11 expression in human airway smooth muscle cells: role of MAPK (Erk1/2, JNK, and p38) pathways. J Immunol (2006) 1.29
Mitogen-activated protein kinases regulate cytokine gene expression in human airway myocytes. Am J Respir Cell Mol Biol (2000) 1.27
TGF-beta1 increases proliferation of airway smooth muscle cells by phosphorylation of map kinases. Respir Res (2006) 1.26
Ikappa-B kinase-2 inhibitor blocks inflammation in human airway smooth muscle and a rat model of asthma. Am J Respir Crit Care Med (2005) 1.24
Fractalkine/CX3CL1 production by human airway smooth muscle cells: induction by IFN-gamma and TNF-alpha and regulation by TGF-beta and corticosteroids. Am J Physiol Lung Cell Mol Physiol (2004) 1.24
Persistent activation of nuclear factor-kappaB signaling pathway in severe uncontrolled asthma. Am J Respir Crit Care Med (2003) 1.23
Toll-like receptor-4 mediates cigarette smoke-induced cytokine production by human macrophages. Respir Res (2006) 1.20
IL-17A acts via p38 MAPK to increase stability of TNF-alpha-induced IL-8 mRNA in human ASM. Am J Physiol Lung Cell Mol Physiol (2006) 1.20
CD38 expression is insensitive to steroid action in cells treated with tumor necrosis factor-alpha and interferon-gamma by a mechanism involving the up-regulation of the glucocorticoid receptor beta isoform. Mol Pharmacol (2005) 1.19
Cytokines induce an early steroid resistance in airway smooth muscle cells: novel role of interferon regulatory factor-1. Am J Respir Cell Mol Biol (2007) 1.16
Agonists of toll-like receptors 2 and 4 activate airway smooth muscle via mononuclear leukocytes. Am J Respir Crit Care Med (2005) 1.16
Signaling pathways regulating interleukin-13-stimulated chemokine release from airway smooth muscle. Am J Respir Crit Care Med (2003) 1.15
Retracted Kinase inhibitors and airway inflammation. Eur J Pharmacol (2006) 1.15
Transcriptional regulation of VCAM-1 expression by tumor necrosis factor-alpha in human tracheal smooth muscle cells: involvement of MAPKs, NF-kappaB, p300, and histone acetylation. J Cell Physiol (2006) 1.14
Inhibition of T helper 2-type responses, IgE production and eosinophilia by synthetic lipopeptides. Eur J Immunol (2003) 1.14
Tumor necrosis factor alpha modulates airway smooth muscle function via the autocrine action of interferon beta. J Biol Chem (2003) 1.13
Murine TLR4 is implicated in cigarette smoke-induced pulmonary inflammation. Int Arch Allergy Immunol (2006) 1.12
Immunomodulatory effects of viral TLR ligands on experimental asthma depend on the additive effects of IL-12 and IL-10. J Immunol (2007) 1.12
Neutrophil-derived elastase induces TGF-beta1 secretion in human airway smooth muscle via NF-kappaB pathway. Am J Respir Cell Mol Biol (2006) 1.10
Chronic asthma-induced airway remodeling is prevented by toll-like receptor-7/8 ligand S28463. Am J Respir Crit Care Med (2007) 1.09
The allergen Der p1 induces NF-kappaB activation through interference with IkappaB alpha function in asthmatic bronchial epithelial cells. Biochem Biophys Res Commun (1997) 1.09
Cytokine- and virus-stimulated airway smooth muscle cells produce IL-11 and other IL-6-type cytokines. Am J Physiol (1997) 1.09
Synthetic responses in airway smooth muscle. J Allergy Clin Immunol (2004) 1.09
Toll-like receptor 2 down-regulation in established mouse allergic lungs contributes to decreased mycoplasma clearance. Am J Respir Crit Care Med (2008) 1.08
A small molecule inhibitor of redox-regulated NF-kappa B and activator protein-1 transcription blocks allergic airway inflammation in a mouse asthma model. J Immunol (2002) 1.08
IL-9-mediated induction of eotaxin1/CCL11 in human airway smooth muscle cells. J Immunol (2004) 1.07
Involvement of p42/p44 MAPK, p38 MAPK, JNK, and NF-kappaB in IL-1beta-induced VCAM-1 expression in human tracheal smooth muscle cells. Am J Physiol Lung Cell Mol Physiol (2004) 1.07
Mechanisms of persistent NF-kappa B activity in the bronchi of an animal model of asthma. J Immunol (2000) 1.06
Role of c-jun N-terminal kinase in the induced release of GM-CSF, RANTES and IL-8 from human airway smooth muscle cells. Br J Pharmacol (2003) 1.06
Association of IFN-gamma and IFN regulatory factor 1 polymorphisms with childhood atopic asthma. J Allergy Clin Immunol (2001) 1.06
TNF-alpha induced CD38 expression in human airway smooth muscle cells: role of MAP kinases and transcription factors NF-kappaB and AP-1. Am J Physiol Lung Cell Mol Physiol (2007) 1.05
Tumor necrosis factor-alpha differentially regulates the expression of proinflammatory genes in human airway smooth muscle cells by activation of interferon-beta-dependent CD38 pathway. Mol Pharmacol (2004) 1.05
Impact of protein acetylation in inflammatory lung diseases. Pharmacol Ther (2007) 1.05
Attenuation of ozone-induced airway inflammation and hyper-responsiveness by c-Jun NH2 terminal kinase inhibitor SP600125. J Pharmacol Exp Ther (2007) 1.05
Activating p38 MAPK: new tricks for an old kinase. Cell Cycle (2005) 1.05
Tumor necrosis factor receptor (TNFR) 1, but not TNFR2, mediates tumor necrosis factor-alpha-induced interleukin-6 and RANTES in human airway smooth muscle cells: role of p38 and p42/44 mitogen-activated protein kinases. Mol Pharmacol (2001) 1.05
IL-17 enhances IL-1beta-mediated CXCL-8 release from human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol (2006) 1.04
Lipoprotein I, a TLR2/4 ligand modulates Th2-driven allergic immune responses. J Immunol (2005) 1.04
STAT structure and function in signaling. Curr Opin Genet Dev (1998) 1.04
A novel IkappaB kinase-beta inhibitor ameliorates bleomycin-induced pulmonary fibrosis in mice. Am J Respir Crit Care Med (2006) 1.02
TGF-beta potentiates airway smooth muscle responsiveness to bradykinin. Am J Physiol Lung Cell Mol Physiol (2005) 1.51
Altered O-glycosylation and sulfation of airway mucins associated with cystic fibrosis. Glycobiology (2005) 1.38
TGF-β regulates Nox4, MnSOD and catalase expression, and IL-6 release in airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol (2010) 1.29
Regulation of TGF-beta 1-induced connective tissue growth factor expression in airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol (2004) 1.24
Airway smooth muscle as an immunomodulatory cell. Pulm Pharmacol Ther (2008) 1.20
TNF-[alpha] modulates murine tracheal rings responsiveness to G-protein-coupled receptor agonists and KCl. J Appl Physiol (1985) (2003) 1.16
Cytokines induce an early steroid resistance in airway smooth muscle cells: novel role of interferon regulatory factor-1. Am J Respir Cell Mol Biol (2007) 1.16
Mechanisms of induction of airway smooth muscle hyperplasia by transforming growth factor-beta. Am J Physiol Lung Cell Mol Physiol (2007) 1.09
Synthetic responses in airway smooth muscle. J Allergy Clin Immunol (2004) 1.09
Intergroup peer assessment in problem-based learning tutorials for undergraduate pharmacy students. Am J Pharm Educ (2011) 1.07
Role of c-jun N-terminal kinase in the induced release of GM-CSF, RANTES and IL-8 from human airway smooth muscle cells. Br J Pharmacol (2003) 1.06
RAGE and TLRs: relatives, friends or neighbours? Mol Immunol (2013) 1.05
Essential role of IFNbeta and CD38 in TNFalpha-induced airway smooth muscle hyper-responsiveness. Immunobiology (2008) 1.01
GRO-alpha regulation in airway smooth muscle by IL-1beta and TNF-alpha: role of NF-kappaB and MAP kinases. Am J Physiol Lung Cell Mol Physiol (2006) 1.01
Inhibition of tumor necrosis factor-alpha-inducible inflammatory genes by interferon-gamma is associated with altered nuclear factor-kappaB transactivation and enhanced histone deacetylase activity. Mol Pharmacol (2006) 1.01
Social stress enhances allergen-induced airway inflammation in mice and inhibits corticosteroid responsiveness of cytokine production. J Immunol (2009) 1.00
Effect of beta2-adrenoceptor agonists and other cAMP-elevating agents on inflammatory gene expression in human ASM cells: a role for protein kinase A. Am J Physiol Lung Cell Mol Physiol (2008) 0.98
Glucocorticoid suppression of CX3CL1 (fractalkine) by reduced gene promoter recruitment of NF-kappaB. FASEB J (2008) 0.98
Validation of the anti-inflammatory properties of small-molecule IkappaB Kinase (IKK)-2 inhibitors by comparison with adenoviral-mediated delivery of dominant-negative IKK1 and IKK2 in human airways smooth muscle. Mol Pharmacol (2006) 0.98
Bronchial hyperresponsiveness: insights into new signaling molecules. Curr Opin Pharmacol (2004) 0.98
Induction and regulation of matrix metalloproteinase-12 in human airway smooth muscle cells. Respir Res (2005) 0.97
Glucocorticoid receptor interacting protein-1 restores glucocorticoid responsiveness in steroid-resistant airway structural cells. Am J Respir Cell Mol Biol (2009) 0.97
C-027 inhibits IgE-mediated passive sensitization bronchoconstriction and acts as a histamine and serotonin antagonist in human airways. Allergy Asthma Proc (2011) 0.95
Signal transducer and activator of transcription 3 is required for abnormal proliferation and survival of TSC2-deficient cells: relevance to pulmonary lymphangioleiomyomatosis. Mol Pharmacol (2009) 0.95
Vascular endothelial growth factor-induced secretion of fibronectin is ERK dependent. Am J Physiol Lung Cell Mol Physiol (2003) 0.94
Cytokines alter glucocorticoid receptor phosphorylation in airway cells: role of phosphatases. Am J Respir Cell Mol Biol (2012) 0.94
Trichostatin A abrogates airway constriction, but not inflammation, in murine and human asthma models. Am J Respir Cell Mol Biol (2012) 0.92
Bradykinin induces interleukin-6 production in human airway smooth muscle cells: modulation by Th2 cytokines and dexamethasone. Am J Respir Cell Mol Biol (2003) 0.91
The effect of IL-13 and IL-13R130Q, a naturally occurring IL-13 polymorphism, on the gene expression of human airway smooth muscle cells. Respir Res (2005) 0.89
Differential expression of MUC genes in endometrial and cervical tissues and tumors. BMC Cancer (2005) 0.86
IFN-gamma inhibits human airway smooth muscle cell proliferation by modulating the E2F-1/Rb pathway. Am J Physiol Lung Cell Mol Physiol (2003) 0.86
Interferon beta augments tuberous sclerosis complex 2 (TSC2)-dependent inhibition of TSC2-null ELT3 and human lymphangioleiomyomatosis-derived cell proliferation. Mol Pharmacol (2007) 0.86
Differential regulation of CCL-11/eotaxin-1 and CXCL-8/IL-8 by gram-positive and gram-negative bacteria in human airway smooth muscle cells. Respir Res (2008) 0.85
Beta-agonist-associated reduction in RGS5 expression promotes airway smooth muscle hyper-responsiveness. J Biol Chem (2011) 0.83
Histamine stimulation of MMP-1(collagenase-1) secretion and gene expression in gastric epithelial cells: role of EGFR transactivation and the MAP kinase pathway. Int J Biochem Cell Biol (2007) 0.83
Induction of human airway smooth muscle apoptosis by neutrophils and neutrophil elastase. Am J Respir Cell Mol Biol (2005) 0.82
Regulator of G-protein signaling-5 inhibits bronchial smooth muscle contraction in severe asthma. Am J Respir Cell Mol Biol (2012) 0.82
TLR2 ligand engagement upregulates airway smooth muscle TNFα-induced cytokine production. Am J Physiol Lung Cell Mol Physiol (2012) 0.82
Early and transient cytotoxic response of peritoneal cells from Fasciola hepatica-infected rats. Vet Res (2004) 0.81
Basal p38 mitogen-activated protein kinase regulates unliganded glucocorticoid receptor function in airway smooth muscle cells. Am J Respir Cell Mol Biol (2014) 0.81
Targeting airway smooth muscle in airways diseases: an old concept with new twists. Expert Rev Respir Med (2011) 0.79
Inhibition of airway smooth muscle adhesion and migration by the disintegrin domain of ADAM-15. Am J Respir Cell Mol Biol (2007) 0.79
G-protein-coupled receptor agonists differentially regulate basal or tumor necrosis factor-alpha-stimulated activation of interleukin-6 and RANTES in human airway smooth muscle cells. J Biomed Sci (2005) 0.78
Deletion of microsomal prostaglandin E synthase-1 does not alter ozone-induced airway hyper-responsiveness. J Pharmacol Exp Ther (2010) 0.78
Proteomic analysis of extracellular HMGB1 identifies binding partners and exposes its potential role in airway epithelial cell homeostasis. J Proteome Res (2017) 0.75